This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignees: Diabetym Co., Ltd., Kinki University. Active years: 2009-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2009)
- Higashiosaka, JP (2015)
Company Filing History:

Years Active: 2009-2015
Title: Genzoh Tanabe: Innovator in Diabetes Treatment
Introduction
Genzoh Tanabe is a notable inventor based in Higashiosaka, Japan. He has made significant contributions to the field of diabetes treatment through his innovative research and development of novel compounds. With a total of two patents to his name, Tanabe's work focuses on cyclic sulfonium salts and their applications in healthcare.
Latest Patents
Tanabe's latest patents include a cyclic sulfonium salt and a process for its production, as well as an α-glucosidase inhibitor that incorporates this compound. The cyclic sulfonium salt is particularly valuable for the prevention and treatment of diabetes. His inventions are represented by general formulas that describe the structure and potential applications of these compounds. The α-glucosidase inhibitor and related pharmaceutical compositions aim to provide effective solutions for managing diabetes and improving patient outcomes.
Career Highlights
Throughout his career, Genzoh Tanabe has worked with esteemed institutions such as Kinki University and Diabetym Co., Ltd. His research has led to advancements in the understanding and treatment of diabetes, showcasing his commitment to improving health through innovation.
Collaborations
Tanabe has collaborated with notable colleagues, including Osamu Muraoka and Masayuki Yoshikawa. These partnerships have contributed to the development of his patents and the advancement of diabetes treatment methodologies.
Conclusion
Genzoh Tanabe's contributions to the field of diabetes treatment through his innovative patents highlight his role as a significant inventor. His work continues to impact the healthcare industry positively, providing new avenues for diabetes management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile